Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$825M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$813M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
|
+$802M |
| 4 |
iShares MSCI India ETF
INDA
|
+$743M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 2 |
Microsoft
MSFT
|
+$2.08B |
| 3 |
NVIDIA
NVDA
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Netflix
NFLX
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.41% |
| 2 | Consumer Discretionary | 1.14% |
| 3 | Financials | 1.02% |
| 4 | Healthcare | 0.75% |
| 5 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERO
8501
DELISTED
CERo Therapeutics
CERO
| $81.4K | ﹤0.01% |
+13
| New | +$145K |
|
|
TWOU
8502
DELISTED
2U Inc
TWOU
| $81.3K | ﹤0.01% |
6,954
-14,956
| -68% | -$291K |
|
|
DADA
8503
CALL
DELISTED
Dada Nexus
DADA
| $81.2K | ﹤0.01% |
+39,600
| New | +$84.7K |
|
8504
CALL
Travere Therapeutics
TVTX
$5.74B
| $81K | ﹤0.01% |
10,500
-32,800
| -76% | -$277K |
|
8505
PUT
The RealReal
REAL
$1.45B
| $80.9K | ﹤0.01% |
20,700
-11,400
| -36% | -$27.2K |
|
8506
CALL
CytomX Therapeutics
CTMX
$750M
| $80.9K | ﹤0.01% |
+37,100
| New | +$68.5K |
|
8507
PUT
GDS Holdings
GDS
$6.29B
| $80.5K | ﹤0.01% |
+12,100
| New | +$82K |
|
8508
Talkspace
TALK
$878M
| $80.5K | ﹤0.01% |
22,538
-33,412
| -60% | -$90.8K |
|
|
TIGR
8509
PUT
UP Fintech Holding
TIGR
$877M
| $80.2K | ﹤0.01% |
23,300
-5,100
| -18% | -$20.2K |
|
8510
Perspective Therapeutics
CATX
$342M
| $79.8K | ﹤0.01% |
6,706
+5,405
| +415% | +$46.1K |
|
|
RPTX
8511
DELISTED
Repare Therapeutics
RPTX
| $79.8K | ﹤0.01% |
16,934
-11,501
| -40% | -$73.7K |
|
8512
Ribbon Communications
RBBN
$367M
| $79.5K | ﹤0.01% |
24,855
-23,047
| -48% | -$70.1K |
|
8513
Duluth Holdings
DLTH
$151M
| $79.5K | ﹤0.01% |
16,226
+4,788
| +42% | +$23.4K |
|
8514
CALL
Bitdeer Technologies
BTDR
$2.12B
| $79.3K | ﹤0.01% |
+11,300
| New | +$82.8K |
|
8515
CALL
Leslie's
LESL
$10.4M
| $79.3K | ﹤0.01% |
610
-875
| -59% | -$125K |
|
|
NIOBW
8516
NioCorp Developments Ltd Warrant
NIOBW
$82.1M
| $78.4K | ﹤0.01% |
201,049
| – | – |
|
|
TCON
8517
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $78.4K | ﹤0.01% |
+9,115
| New | +$43.5K |
|
|
CTLP
8518
DELISTED
Cantaloupe
CTLP
| $78.3K | ﹤0.01% |
12,176
-24,785
| -67% | -$163K |
|
8519
Prelude Therapeutics
PRLD
$385M
| $77.7K | ﹤0.01% |
16,388
-16,589
| -50% | -$64.5K |
|
8520
Immunic
IMUX
$192M
| $77.3K | ﹤0.01% |
+5,852
| New | +$76K |
|
|
SHCR
8521
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $77.2K | ﹤0.01% |
100,641
-35,339
| -26% | -$35.4K |
|
8522
Destination XL Group
DXLG
$31.2M
| $77.1K | ﹤0.01% |
21,407
-191,886
| -90% | -$753K |
|
|
TDAY
8523
USA Today Co
TDAY
$1.05B
| $77K | ﹤0.01% |
31,566
-64,080
| -67% | -$144K |
|
8524
Fractyl Health
GUTS
$107M
| $77K | ﹤0.01% |
+10,399
| New | +$87.5K |
|
8525
Accuray
ARAY
$34.9M
| $76.8K | ﹤0.01% |
31,087
-13,585
| -30% | -$36.4K |
|
Similar funds
Jane Street's Q1 2024 Portfolio in Review
As of Q1 2024, Jane Street held 10,498 positions worth $478B, up 25% from $384B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Jane Street deployed $55.3B of net new capital in Q1 2024, opening 1,391 new positions and adding to 3,225 existing holdings. Its largest new stake was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 4.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.37B trimmed.
- Jane Street's largest Q1 2024 buy was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
- Jane Street added most to iShares MSCI ACWI ETF in Q1 2024, an estimated $825M increase.
- Jane Street's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.37B.
- Jane Street fully exited JPMorgan Ultra-Short Income ETF in Q1 2024, selling an estimated $302M.
- Jane Street's ten largest holdings make up 51% of its $478B portfolio in Q1 2024.
- Jane Street opened 1,391 new positions and closed 1,402 in Q1 2024.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $478B.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.